PTH and hyperuricemia: Conversely, hyperuricemia promotes CKD progression via vascular, inflammatory, and fibrotic pathways, exacerbating mineral disturbances such as phosphate retention, hypocalcemia, and reduced vitamin D activation, thereby promoting PTH secretion and parathyroid hyperplasia and resulting in SHPT [80,81].